SCHEMBL14698123

SCHEMBL14698123

CC(C)[Si](OCc1ccc(NCC(C)(C)O)c(N)c1)(C(C)C)C(C)C

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.32
▸ PRSS1 P07477 8/20 0.32
▸ CCNT1 O60563 1/20 0.32
▸ CCNE1 P24864 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ CDK7 P50613 1/20 0.32
▸ CDK9 P50750 1/20 0.32
▸ CCNH P51946 1/20 0.32
▸ CDK5 Q00535 1/20 0.32
▸ CDK5R1 Q15078 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ GFER P55789 1/20 0.31
▸ PLEC Q15149 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21311033 0.76 GAA (0.41) PRSS1HDAC6KDM4EALDH1A1GAA
SCHEMBL14708998 0.74 INSR (0.33) PRSS1CCNT1CCNE1CDK2CDK7
SCHEMBL21311034 0.74 ALDH1A1 (0.46) PRSS1CCNT1CCNE1CDK2CDK7
SCHEMBL21310771 0.72 GAA (0.58) KDM4EALDH1A1GAAMAPTTHRB
SCHEMBL21310905 0.71 THRB (0.34) PRSS1HDAC6KDM4EALDH1A1GAA
SCHEMBL21310772 0.71 HDAC6 (0.48) PRSS1HDAC6KDM4EALDH1A1GAA
SCHEMBL21310782 0.70 AAK1 (0.40) PRSS1HDAC6KDM4EALDH1A1GAA
SCHEMBL15323160 0.70 HDAC1 (0.44) PRSS1KDM4EALDH1A1GAAMAPT
SCHEMBL21311042 0.70 HDAC1 (0.40) PRSS1CCNE1CDK2CDK7CCNH
SCHEMBL20282982 0.69 LNPEP (0.45) HDAC6GAAMAPTLNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013024427-A1 NOVEL UREA DERIVATIVES AS TEC KINASE INHIBITORS AND USES THEREOF GLENMARK PHARMACEUTICALS S.A. (CH) 2013-02-21 — — WO disclosed
Send feedback